文献速递免疫规划卫生政策与健康促进

法国COVID-19疫苗临床试验中志愿者参与意愿、动机与障碍的相关因素:一项混合方法研究

Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: A mixed-method study.
PubMed 文献 · Vaccine · 2024-06-22

研究对COVIREIVAC平台上注册的56101名志愿者中的2741名(4.9%)进行混合方法调查,并按注册时间分为早期、中期和晚期志愿者,另对16人进行面对面访谈。结果显示晚期志愿者更年轻、教育水平较低且对疫苗态度更不积极,主要参与动机为利他主义,74.5%的受访者会考虑参与非COVID-19疫苗临床试验。

要点

  • 早期与中期志愿者在年龄、教育水平及5C模型疫苗态度上无差异。
  • 晚期志愿者较早期和中期志愿者显著更年轻、教育水平更低且疫苗态度更不积极。
  • 主要参与动机为利他主义,尤其在早期和中期志愿者中;晚期志愿者希望选择疫苗技术。

核心结论

  • COVIREIVAC平台上的晚期志愿者与早期和中期志愿者特征不同,且对疫苗信心较低。
  • 恢复对疫苗和临床研究的信心可能有助于吸引更多样化的人群参与疫苗临床试验。

研究设计与样本

  • 混合方法研究:对COVIREIVAC平台注册志愿者进行问卷调查,并对COVID-19疫苗临床试验参与者进行半定向访谈。
  • 志愿者分为早期志愿者(COVID-19疫苗接种运动启动前注册)、中期志愿者(2021年1月1日至2021年5月COVID-19疫苗接种推广至全体人群期间注册)和晚期志愿者(此后注册)。
  • 56101名注册志愿者中2741名(4.9%)完成调查,其中早期志愿者1915名(69.6%)、中期志愿者301名(11.0%)、晚期志愿者525名(19.2%);16人接受面对面访谈。

主要发现

  • 早期与中期志愿者在年龄、教育水平及采用5C模型评估的疫苗态度上无差异。
  • 女性性别和可选择疫苗平台与成为中期志愿者相关。
  • 晚期志愿者较早期和中期志愿者显著更年轻、教育水平更低且对疫苗态度更不积极。
  • 参与疫苗临床试验的主要动机为利他主义,尤其在早期和中期志愿者中;晚期志愿者注册是希望选择疫苗技术。
  • 2041名(74.5%)受访者会考虑参与非COVID-19疫苗临床试验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: During the COVID-19 pandemic, there was an unprecedented effort to engage people in clinical vaccine research. Most of the French volunteers registered in the first weeks after the launch in October 2020 of COVIREIVAC, an electronic platform dedicated to COVID-19 vaccine clinical trials (VCT). In the context of pandemic preparedness, identifying factors associated with eagerness or hesitancy to participate in VCT may help to increase recruitment of volunteers from diverse backgrounds. METHODS: We used a mixed-method survey offered to the volunteers registered on the COVIREIVAC platform, and semi-directed interviews in participants to COVID-19 VCTs. Volunteers were divided into three categories: early volunteers (EV), registered before the launch of the COVID-19 vaccination campaign, middle volunteers (MV) registered between the first of January 2021 and the generalization of the COVID-19 vaccination to the entire population in May 2021, and late volunteers (LV) registered afterward. RESULTS: Among the 56,101 COVIREIVAC registered volunteers, 2,741 (4.9 %) completed the survey, 1,915 (69.6%) were EV, 301 (11.0%) were MV and 525 (19.2 %) were LV. Sixteen were face-to-face interviewed. Age, educational level, attitudes toward vaccination evaluated with the 5C-model did not differ between EV and MV. Women gender and the possibility to choose the vaccine platform was associated with being a MV. LV were significantly younger, had a lower educational level and had less positive attitudes toward vaccines than EV and MV. The main motivations for participation in VCTs were altruistic notably in EV and MV. For LV, they registered in the hope to choice the vaccine technology. Among the respondents, 2,041 (74.5 %) would consider to participate in a non-COVID-19 VCT. CONCLUSION: LV on the COVIREIVAC platform had a distinct profile from EV and MV, and were less confident in vaccines. Restoring confidence in vaccines and clinical may help to engage more diverse populations in VCTs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Helary A, Botelho-Nevers E, Bonneton M, et al. Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: A mixed-method study. Vaccine. 2024. PMID: 38910094. doi:10.1016/j.vaccine.2024.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。